Previous Article | Next Article ![]()
Journal of Clinical Microbiology, February 2000, p. 591-594, Vol. 38, No. 2
Provincial Laboratory of Public Health,
Calgary, Alberta, Canada, T2N 4W4,1 and
Department of Microbiology and Infectious Diseases, The
University of Calgary, Calgary, Alberta, Canada T2N
4N12
Received 29 July 1999/Returned for modification 28 September
1999/Accepted 1 November 1999
In many developing countries sheep and horse blood, the recommended
blood supplements in bacteriological media, are not readily available,
whereas pig and goat blood are. Therefore, this study examined the use
of pig and goat blood as potential substitutes for sheep blood in
blood-supplemented bacteriologic media commonly used in clinical
microbiology laboratories. In general, the growth characteristics and
colony morphologies of a wide range of aerobic and anaerobic bacteria
and Candida albicans were similar on media containing pig,
goat, and sheep blood, although differences were found.
Enterococcus sp. uniformly produced alpha-hemolysis when incubated in CO2, but in anaerobic conditions the hemolysis
varied. In contrast, beta-hemolytic streptococci produced identical
hemolytic reactions on all three media. Synergistic hemolysis was not
observed on pig blood agar in the CAMP test nor on goat blood agar in
the reverse CAMP test. The preparation of chocolate agar (heated) with
pig blood required heating to a higher temperature than with sheep or
goat blood to yield suitable growth of Haemophilus species. In general, we conclude that pig and goat blood are suitable
alternatives to sheep blood for use in bacteriological media in
settings where sheep and horse blood are not readily available.
A variety of animal bloods and
banked human blood (BHB) are used to enrich microbiological culture
media and to highlight growth characteristics such as hemolysis. In
most clinical microbiology laboratories, the selection of colonies from
primary cultures for further workup as putative beta-hemolytic
streptococci (BHS) is made on the basis of the hemolytic reaction on
blood agar (BA) as well as the colonial morphology. On BA, the
hemolysis produced by streptococci and enterococci varies depending on
the blood type contained in the media. Organisms such as
Haemophilus haemolyticus also produce hemolytic colonies,
which, on the basis of morphology, can be confused with those of BHS
(3, 8). Thus, the selection of inappropriate colonies could
result in an increase in technical cost to process specimens and also
add to the turnaround time. In North American clinical laboratories,
defibrinated sheep blood (SB) is accepted as the most efficient blood
supplement for routine work because the hemolytic reactions of BHS on
BA prepared with SB are deemed "true," and it is used as the
standard for defining hemolytic reactions of streptococci
(9). Horse blood (HB) is recommended as the second choice
and is widely used in European countries (3, 9). In many
developing countries, SB and HB are not readily available, probably
because of local animal husbandry practices, making these animal bloods
relatively expensive in the setting of meager resources. Another blood
extensively used in these countries to prepare BA is BHB, which is
generally available cost free to laboratories when it is approaching
the end of its shelf life and is no longer used as a transfusion
product. The anticoagulant used in BHB contains citrate and dextrose,
and the adverse effects of these additives in bacteriological media
have been well documented (3, 9). In many developing
countries there is a high prevalence of blood-borne pathogens, such as
hepatitis B virus, human immunodeficiency virus, and hepatitis C virus, and because of the lack of adequate safety precautions in the laboratory, the use of BHB potentially poses a significant risk to the
laboratory staff.
In many of these countries, goats, pigs, or both are more readily
available than sheep or horses and constitute an alternative source of
blood for use in bacteriological media. However, published data on the
growth characteristics of pathogenic bacteria on media supplemented
with pig blood (PB) and goat blood (GB) are limited (4, 5).
This study was undertaken to define the growth characteristics of
pathogenic bacteria cultured on PB- and GB-based media compared to
those on the SB-based media routinely used in clinical laboratories with a view to offering an alternative in settings where SB and HB are
not readily available.
Blood.
Defibrinated blood was collected aseptically by
jugular vein puncture from antibiotic-free pigs and goats housed in the
animal farm of the University of Calgary, Calgary, Alberta, Canada.
Blood was collected from five animals of each species. Defibrinated SB
was purchased from Western Biological Products Ltd., Calgary, Alberta,
Canada. The blood was stored in plastic containers at 4°C and used
within 2 to 7 days of collection.
Media.
The media evaluated, which are used in routine
microbiology and are enriched with blood, are listed in Table
1. Each medium was prepared with SB, GB,
or PB under identical conditions and with identical ingredients
according to the instructions in reference 9 or the
manufacturers' recommendations.
0095-1137/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
Pig and Goat Blood as Substitutes for Sheep Blood
in Blood-Supplemented Agar Media
![]()
ABSTRACT
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
![]()
INTRODUCTION
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
![]()
MATERIALS AND METHODS
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
TABLE 1.
Blood-supplemented media tested, medium base, and
concentrations of SB, GB, and PB
Organisms. Five different clinical isolates of each of the following organisms and the American Type Culture Collection strains indicated by the numbers in parentheses were tested: group A streptococcus (19615), group B streptococcus (GBS) (13813), group C streptococcus (12388), group F streptococcus, Streptococcus sanguis, Streptococcus pneumoniae (49619), Enterococcus faecalis (29212), Enterococcus faecium, Staphylococcus aureus (25923), Staphylococcus epidermidis (12228), Corynebacterium diphtheriae (8028), Neisseria meningitidis (13007), Neisseria gonorrhoeae (49226), Haemophilus influenzae (10211), Haemophilus parainfluenzae (7901), H. haemolyticus (33390), Haemophilus aphrophilus (33389), Haemophilus ducreyi (33940), Escherichia coli (35218), Pseudomonas aeruginosa (27853), Candida albicans (14053), Clostridium difficile, Clostridium sporogenes, Clostridium perfringens (13124), and Bacteroides fragilis (2528) Bordetella pertussis (9340), Bordetella parapertussis (15311), and Campylobacter jejuni (29428).
The clinical strains were fresh isolates from patient samples or were recovered from lyophilized cultures or isolates preserved at
70°C
in brain heart infusion-glycerol broth.
Inoculation of media.
A suspension of each isolate in 0.9%
saline was prepared from an overnight culture and adjusted to 0.5 McFarland standard density. Ten microliters was inoculated onto
separate media containing SB, GB, or PB and streaked for single-colony
isolation. A single streak of S. aureus was made on blood
agar plates inoculated for growth of Haemophilus spp. The
plates were incubated at 35°C aerobically, in 5% CO2, or
anaerobically as appropriate for the optimum growth of each organism
(Table 2) and read at 48 h, except
for Regan-Lowe medium, which was incubated for up to 7 days. Plates of
Skirrow's medium for the culture of C. jejuni were
incubated at 42°C under microaerophilic conditions.
|
CAMP and reverse CAMP tests. The CAMP test for synergistic hemolysis between GBS and S. aureus for the presumptive identification of GBS (2) and the reverse CAMP test for synergistic hemolysis between GBS and C. perfringens (7) for the presumptive identification of the latter organism were evaluated on SB, GB, and PB. In the CAMP test, a single streak of a beta-hemolytic S. aureus was made across the middle of the blood agar plate under evaluation and the GBS was cross-streaked at right angles to within 1 to 2 mm of the first streak. Similarly, for the reverse CAMP test a single central streak of C. perfringens and a cross-streak of GBS were made. The plates were incubated in CO2 for the CAMP test and anaerobically for the reverse CAMP test at 35°C for 24 h. The presence of an arrowhead-shaped area of synergistic hemolysis in the intersecting area indicated a positive result.
| |
RESULTS |
|---|
|
|
|---|
The growth characteristics and colony morphologies of organisms were assessed according to medium type and incubation conditions by two of us for comparison. The organisms which displayed similar colony morphologies and growth characteristics on media containing SB, PB, and GB are reported in Table 2.
All 11 strains of Enterococcus spp. produced alpha-hemolysis on SBA, GBA, and PBA when incubated in CO2. Under anaerobic growth conditions, one strain of E. faecium was alpha-hemolytic on SBA but nonhemolytic on GBA and PBA. E. faecalis ATCC 29212 was beta-hemolytic, five E. faecalis strains and two E. faecium strains were nonhemolytic, and two strains of E. faecium were alpha-hemolytic on SBA, GBA, and PBA.
Strains of BHS groups A, B, C, F, and G grew equally well and gave identical hemolytic reactions on SBA, PBA, and GBA, although individual isolates displayed variation in the size of the hemolytic zone and/or sharpness of the zone edge on the different BAs. Colonies of S. pneumoniae were dome shaped and more mucoid on PBA compared to colonies on SBA and GBA, which were flat with a central depression.
Table 3 illustrates the differences
observed on the various media. The maximum growth of H. influenzae was observed on SBCHA prepared at 80°C for 5 min,
with an average colony size of 5 mm; on GBCHA prepared at 80°C for 15 min, with an average colony size of 4 mm; and on PBCHA prepared at
100°C for 15 min, with a colony size of 3 mm. For H. parainfluenzae, maximum growth was observed on SBCHA and GBCHA
prepared at 100°C for 15 min, with colony sizes of 3 and 2 mm,
respectively, compared to 1.5 and 0.5 mm on SBCHA and GBCHA,
respectively, prepared at 80°C for 15 min, whereas on PBCHA prepared
at 100°C for 15 min, a colony size of 0.5 mm was observed. On media
produced at 70°C for 15 min, H. influenzae produced
colonies 0.5 mm in size on SBCHA and GBCHA and only a hazy growth on
PBCHA, whereas H. parainfluenzae failed to grow.
|
H. haemolyticus failed to grow on PBA and GBA except as satellite growth around the Staphylococcus streak, and on PBCHA and GBCHA the growth characteristics were similar to those of H. influenzae.
The results of the CAMP and reverse CAMP tests are presented in Table 3. Notably, synergistic hemolysis was not observed in the CAMP test on PBA or in the reverse CAMP test on GBA.
| |
DISCUSSION |
|---|
|
|
|---|
Published data on the growth characteristics of pathogenic bacteria on media supplemented with GB are limited to two studies (4, 5), and as far as we could ascertain, there are no studies of PB. Feinsod and Kim (4) examined GB with a limited range of bacteria and yeasts and did not examine specialized media supplemented with blood required for the growth of organisms such as Bordetella spp., Campylobacter spp., and anaerobic bacteria or procedures such as the CAMP test, which require blood-based media. Furthermore, the base media which they used to prepare BA and CHA with SB were different from those used to prepare BA and CHA with GB; therefore, the effect of blood per se could not be assessed. Gratten et al. (5) evaluated selective and nonselective BA and CHA prepared with GB and compared them to similar media prepared with HB, but their study was limited to growth of H. influenzae and S. pneumoniae.
In this study we compared most media commonly used in a clinical laboratory for which blood supplement is required prepared with PB or GB, using identically prepared SB as a reference. We are confident that PB and GB can be substituted for almost all media for which SB is used within certain limitations discussed below.
Our observations regarding the hemolytic reactions of the BHS groups A, B, C, F, and G are similar to those reported by Updyke, who also noted that variations in hemolytic activity were restricted to Enterococcus spp. (8). In her report, 88% of group D strains were alpha-hemolytic on SBA but beta-hemolytic on rabbit, horse, and human blood agars. Our observations differed in that the hemolytic reactions of all enterococci strains that we tested were alpha-hemolytic on SBA, PBA, and GBA when incubated in CO2 but under anaerobic incubation were either alpha- or nonhemolytic, except for E. faecalis ATCC 29212, which was beta-hemolytic. Although there was interstrain variability in the type of hemolysis, each individual strain gave identical hemolysis on all three blood types. Therefore the majority of Enterococcus isolates would not be selected for further testing as potential BHS on the basis of their hemolysis on GBA and PBA, although the occasional isolate, as exemplified by E. faecalis ATCC 29212, may be confused. The literature shows that animal blood naturally contains the thermolabile growth inhibitors for pyridine nucleotide (NAD or NADP)-requiring Haemophilus spp. and that the heat susceptibilities of these vary with the animal species (1, 6). Furthermore, there is a critical time and temperature threshold that must be achieved during medium production to eliminate them (1, 6). The quality of CHA prepared with heated animal blood can therefore vary depending on the animal blood can therefore vary depending on the animal blood and the time and temperature used in its preparation. In developed countries, chocolate agar prepared with a defined base, such as Mueller-Hinton agar or GC medium base, and supplemented with a mixture of hemoglobin and a synthetic cocktail of chemically defined supplements, such as Isovitelex (BBL, Cockeysville, Md.) has largely replaced CHA (heated). In developing countries these supplements are often cost prohibitive, and CHA (heated), which is much cheaper and simpler to prepare, still has utility for the isolation of fastidious organisms such as Neisseria spp. and Haemophilus spp. However, its preparation needs to be carefully controlled to ensure adequate removal of these inhibitors. We found the time-temperature combination of 80°C for 15 min, as recommended by Vera and Powers (9) for SBCHA, to be adequate for both SBCHA and GBCHA but not for PBCHA, which required a higher temperature of 100°C for 15 min for better growth. However, we did not evaluate longer times at this temperature for this organism. Our finding for the optimum time-temperature combination for GB is at variance with that of Gratten et al. (5), who recommended 100°C for 15 min. However, we support their recommendation, since heating the medium to this temperature removes inhibitors of H. influenzae and H. parainfluenzae from all blood types which we tested without adversely affecting the medium for the isolation of Neisseria spp. Thermolabile inhibitors of Haemophilus spp. are known to be qualitatively variable in blood of different animals, and both SB and GB are known to possess high NADase activity compared to HB and rabbit blood (1). Our findings suggest that NADase activity in PB is likely to be even greater. We recommend greater care in the preparation of heated PBCHA and GBCHA and subsequent quality control to ensure that an adequate time-temperature combination has been achieved.
A drawback of PB is that it cannot be used for the presumptive identification of GBS with the CAMP test, which would be useful in developing countries, where there is often a limited availability of antisera for serogrouping streptococci. Similarly, the reverse CAMP test, which is a simple test for the presumptive identification of C. perfringens, works satisfactorily on PBA. On GBA, the lack of synergistic hemolysis in the form of an arrowhead makes this reaction unreliable, and the results need to be interpreted with caution. This phenomenon may be related to the observation that the double zone of hemolysis produced by C. perfringens on SBA and PBA was absent on GBA.
A point that we noted in the phlebotomy of the animals is that it is easier to obtain blood from goats than from pigs. Therefore, where access to both animals is equal, GB would be the preferred choice.
In conclusion, PB and GB can almost always be substituted for SB for bacterial isolation and in identification steps for organisms commonly encountered in a clinical laboratory.
| |
ACKNOWLEDGMENTS |
|---|
We gratefully acknowledge the help provided by Nilo Kee and Dorothy Cave in the preparation of media.
| |
FOOTNOTES |
|---|
* Corresponding author. Mailing address: Provincial Laboratory of Public Health, 3030 Hospital Dr. NW, Calgary, Alberta, Canada, T2N 4W4. Phone: (403) 670-1201. Fax: (403) 270-2216. E-mail: chandar.anand{at}crha-health.ab.ca.
| |
REFERENCES |
|---|
|
|
|---|
| 1. | Artman, M., and G. Frankl. 1982. Nicotinamide adenine dinucleotide and nicotinamide adenine dinucleotide phosphate splitting enzyme(s) of sheep and rabbit erythrocytes: their effect on the growth of Haemophilus. Can. J. Microbiol. 28:696-702[Medline]. |
| 2. | Christie, R., N. E. Atkins, and E. Munch-Petersen. 1944. A note on lytic phenomena shown by group B streptococci. Aust. J. Exp. Biol. Med. Sci. 22:197-200. |
| 3. | Facklam, R. R. 1974. Streptococci, p. 96-108. In E. H. Lennette, E. H. Spaulding, and S. P. Truant (ed.), Manual of clinical microbiology, 2nd ed. American Society for Microbiology, Washington, D.C. |
| 4. | Feinsod, F. M., and C. H. Kim. 1986. Goat blood agar. Trop. Doct. 16:117-119[Medline]. |
| 5. |
Gratten, M.,
D. Battistutta,
P. Torzillo,
J. Dixon, and K. Manning.
1994.
Comparison of goat and horse blood as culture medium supplements for isolation and identification of Haemophilus influenzae and Streptococcus pneumoniae from upper respiratory tract secretions.
J. Clin. Microbiol.
32:2871-2872 |
| 6. | Koneman, E. W., S. D. Allen, W. M. Janda, P. C. Schreckenberger, and W. C. Winn, Jr. (ed.). 1997. Color atlas and textbook of diagnostic microbiology, 5th ed., p. 363-393. Lippincott-Raven Publishers, Philadelphia, Pa. |
| 7. | Koneman, E. W., S. D. Allen, W. M. Janda, P. C. Schreckenberger, and W. C. Winn, Jr. (ed.). 1997. Color atlas and textbook of diagnostic microbiology, 5th ed., p. 734-735. Lippincott-Raven Publishers, Philadelphia, Pa. |
| 8. | Updyke, E. L. 1957. Laboratory problems in the diagnosis of streptococcal infections. Public Health Lab. 15:78-80. |
| 9. | Vera, H. D., and D. A. Power. 1980. Culture media, p. 965-999. In E. H. Lennette, A. Ballows, W. J. Housler, Jr., and H. J. Shadomy (ed.), Manual of clinical microbiology, 3rd ed. American Society for Microbiology, Washington, D.C. |
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»